Unruptured Intracranial Aneurysm
Conditions
Brief summary
The goal of this prospective observational cohort study is to learn about treatment strategies for unruptured intracranial aneurysms in the Chinese population. The main questions it aims to answer are: * To establish a cohort of patients with intracranial unruptured aneurysm and explore the optimal clinical treatment strategy. * To establish clinical management path for patients with unruptured intracranial aneurysm. According to the treatment of all patients with unruptured intracranial aneurysm, they were divided into the following groups: 1. Conservative treatment group; 2. Intracranial aneurysm clipping group; 3. Coil embolization or stent-assisted coil embolization group; 4. Flow diversion group.
Interventions
observation
Sponsors
Study design
Eligibility
Inclusion criteria
A. age \> 18 years. B. at least one intracranial aneurysm needs to be treated by craniotomy, endovascular treatment or combined surgery. C. patients' consent were obtained.
Exclusion criteria
1. Ruptured intracranial aneurysms, accompanied by subarachnoid hemorrhage or cerebral hemorrhage ; 2. Traumatic, infectious and atrial myxoma-associated intracranial aneurysms ; 3. Combined with cerebrovascular malformations; 4. Combined with brain tumors or malignant tumors in other parts ; 5. Combined with systemic connective tissue disease and systemic rheumatic disease ; 6. Due to other diseases, or poor general condition, the expected survival time is not more than 12 months ; 7. During pregnancy and perinatal period.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Primary Outcome | 2 years | Functional outcomes(modified Rankin Scale,mRS) at 2 years after treatment decision |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| MACCE events | 1 years | Incidence of major adverse cardiovascular/cerebrovascular events (MACCE events) in patients with atherosclerotic heart disease within 1 year after treatment decision. |
| cardiovascular/cerebrovascular events | 2 years | Incidence of cardiovascular/cerebrovascular events in 2 years after receiving different treatment strategies. |
| Cost | 2 years | Costs associated with unruptured intracranial aneurysms within 2 years after treatment with different strategies. |
| Aneurysm-related bleeding events | 2 years | Incidence of aneurysmal-related bleeding events within 2 years after receiving different treatment strategies. |
| Mortality associated with intracranial aneurysms | 2 years | Mortality associated with intracranial aneurysms within 2 years after treatment with different strategies |
| All-cause mortality | 2 years | All-cause mortality of patients within 2 years after different treatment strategies. |
Countries
China
Contacts
Beijing Tiantan Hospital